Aptahem’s collaboration with Örebro University further increases the understanding of Apta-1
2020-06-30
Aptahem (publ) is a biotech company developing aptamer-based pharmaceuticals for the treatment of life-threatening conditions, such as sepsis. A similar mechanism occurs in cardiovascular diseases where a combination of coagulation and inflammation are involved. Aptahem today announces that the...
Read More